News

Mr Chereau was formerly the vice president and general manager of Genzyme Cardiovascular, a business unit within Genzyme in Cambridge. Mr Chereau also led Genzyme’s cardiovascular business development

All parties involved have agreed on the time line and conditions of this relocation, enabling a smooth transition to the new production facility, the company said. The new

Dr Leigh has previously served as chief medical officer for Paramount Biosciences. Dr Leigh has also held positions at Genentech, Idec Pharmaceuticals, and Biogen Idec where he was

Joint Replacement Instrumentation (JRI) will market its product, the Furlong H-AC hip stem, alongside Active Implants’s TriboFit acetabular system, the only soft bearing articulation product available. TriboFit employs

Analysis of the data indicates that once-daily oral dosing of linaclotide, across a range of doses, significantly reduced abdominal pain and significantly improved constipation symptoms in patients with

Lev stockholders will receive $2.25 in cash, 0.042146 shares of ViroPharma common stock and one non- transferable contingent value right which entitles the holder to receive up to

The company has reported net income of $589 million for the third quarter of 2008, compared to $750 million posted in the third quarter of 2007. Diluted earnings

Under terms of the agreement, Lilly will make an initial cash payment of $125 million to Amylin, and Amylin will supply product for sales in the US and

Pfizer has reported revenues of $12 billion for the third quarter of 2008, consistent with the year-ago quarter, despite the negative impact of the loss of US exclusivity